Please login to the form below
OncoVex
This page shows the latest OncoVex news and features for those working in and with pharma, biotech and healthcare.
AZ signs yet another cancer immunotherapy deal
The most advanced is Amgen's OncoVex (talimogene laherparepvec), which in 2013 became the first oncolytic virus to show efficacy in a phase III trial involving people with the skin cancer
Latest news
-
Amgen says viral melanoma therapy clears phase III trial
OncoVex demonstrates durable response in skin cancer patients. A novel therapy for skin cancer which makes use of the cell-killing activity of a virus has shown efficacy in a phase ... The melanoma immunotherapeutic - talimogene laherparepvec (also known
-
Disease focus: Melanoma
nilotinib. In development. Vaccines. OncoVEX GM-CSF. In development. Vaccines. MAGE-A3 ASCI.
-
Amgen to buy BioVex
BioVex's portfolio includes OncoVex (GM-CSF) – an investigational vaccine to treat melanoma and head and neck cancer. ... Philip Astley-Sparke, CEO, BioVex, also praised the agreement: "Amgen is ideally positioned to leverage the potential of OncoVEX
More from news
Approximately 1 fully matching, plus 3 partially matching documents found.
Featured jobs
-
Senior Medical Writer
-
Salary TBC
- NEW FREELANCE OPPORTUNITIES!!! LONDON and HOME WORKING!
-
EXCELLENT DAY RATES AVAILABLE
-
Midweight Brand Planner
-
Up to £50, 000
- Head of Partnerships - Competitive - London
-
Competitive Salary Offered
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
Subscribe to our email news alerts
- Health comms agency emotive hires new cell and gene therapy leader
- Success breeds success
- RNA-focused biotech Storm Therapeutics raises extra £14m
- Europe responding to gene therapy challenge, but picture remains fragmented
- Turning learning into action: The challenge of behaviour change
- Syncona launches another cell therapy company, Treg specialist Quell
PMHub
mXm Medical Communications
mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...
Latest intelligence
- Success breeds success
- This week we received the exciting news that we have been shortlisted for the Times Business Awards 2019, Tunbridge Wells in the 'Best Business 1-25 Employees' category....
- Turning learning into action: The challenge of behaviour change
- ...
- Investing in our People
- As a small, boutique agency we can and do invest heavily in our team, who produce amazing results for our clients....
Quick links
Infographics
